Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 6Breast Neoplasms 4Sleep Initiation and Maintenance Disorders 3Motor Activity 2Leukemia 2Vomiting 1Renal Insufficiency, Chronic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parasomnias 1Palliative Patients 1Neoplasms 1Nausea 1Liver Cirrhosis 1Heart Diseases 1Head and Neck Neoplasms 1Fatigue 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Anxiety Disorders 1Agnosia 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Breathing Exercises × Clear all
NCT04246970 2025-09-15

PreLiveR-T

Hospital Universitario La Fe

Phase NA Enrolling by invitation
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡